Nineteen yeast colonies secreting rabies virus glycoprotein (G) peptides immunoreactive with polyclonal anti-rabies virus sera were selected from a random expression library. The peptides, around 80 amino acids long, spanned amino acids only recognized by about 1% of our MAbs. Three of these WB + MAbs had significant neutralizing activity; two were used for the selection of antigenic mutants (MAR mutants). Some mutants had a substitution within the region delimited by the peptides, confirming the pertinence of both the peptide and escape mutant approaches. However, a few mutants had a substitution outside the peptide-delimited region, suggesting that remote mutation(s) could affect epitope accessibility in the native protein.
Introduction
Monoclonal antibodies (MAbs) have been widely used to investigate the antigenicity of viral proteins. When MAbs are directed against a protein involved in the neutralization of the infectious power of the pathogen, they can be used to isolate mutants resisting neutralization (MAR mutants) . It is generally admitted, and has been proven to be true in several instances, that mutations conferring resistance to neutralization are generally located in the epitope recognized by the antibody. It is also postulated that if a mutation modifies the sensitivity of the virus to several MAbs, then the epitopes of these MAbs overlap. Overlapping epitopes defines an antigenic site. In the case of the rabies virus glycoprotein (G), this approach has led to the definition of two major antigenic sites (site II and site III), one minor site (site a) and several isolated epitopes (Lafon et al., 1983; Seif et al., 1985; Pr6haud et al., 1988 ; Dietzschold et al., 1990a, b; Benmansour et al., 1991) . Antigenic sites are well defined entities: a mutant * Author for correspondence. Fax +33 1 69 82 43 08. t Present address: Laboratoire de Virologie et Immunologic Moleculaires, Institut National de la Recherche Agronomique, F-78352 Jouy en Josas C6dex, France.
belonging to one antigenic site is still neutralized by all MAbs specific for the other sites and vice versa. Most MAR mutations are located in specific areas of the protein: in two clusters for site II and only one for site III and minor site a, although the three sites are totally conformational and do not survive denaturation (Benmansour et al., 1991) .
MAbs have also been used in competition tests with some success, although several problems such as steric hindrance of the antibodies and different affinity for the antigen complicate the interpretation of the results. This point is best illustrated by the fact that different results can be obtained depending on whether a given MAb is used as a saturating or as a competing MAb. Even if reciprocal tests give similar results (competition or lack of competition) in the case of well defined antigens like the rabies virus glycoprotein, it has been found that two MAbs belonging to two different sites may compete, or reciprocally two MAbs belonging to the same site may not compete (Lafon et al., 1983) .
Another widely used approach is to predict antigenic regions of the protein in order to synthesize peptides and to test their antigenicity with polyclonal sera or MAbs. Antigenic peptides may be inoculated into animals to test their capacity to induce the synthesis of neutralizing 0001-3506 © 1996 SGM antibodies. This peptide approach is often the only method available, particularly for non-neutralizing MAbs, or the only method which has been used to study the antigenicity of a protein. It was therefore of interest to see if peptides could mimic major antigenic sites, which in the case of the rabies virus G protein are strictly dependent on the conformation of the protein. We also wanted to see if we could delineate the limits of the antigenic sites in a different way than by the localization of MAR mutations. Finally, from our collection of several hundred MAbs, only 12 (about 2 %) recognized the protein after denaturation (WB + MAbs). Three of these MAbs were neutralizing. The epitopes recognized by the two preciously described WB + MAbs were not located in established antigenic sites (Bunchoten et al., 1989; Benmansour et al., 1991) . We wanted to determine which regions of the protein had linear epitopes and to localize as precisely as possible the epitopes of our WB + MAbs, whether neutralizing or not.
The yeast expression system of a random peptide library (Brake et al., 1984) seemed particularly suitable for this study; in this method, peptides are secreted into the culture medium and are therefore directly accessible to the antibody without solubilization of the cells. Furthermore, Klepfer et al. (1993) demonstrated that yeast was able to translate the rabies virus G gene as a 68 kDa protein immunoreactive not only with a polyclonal antiserum but also with three neutralizing MAbs that were known to react only with native protein, indicating that the yeast was probably able to efficiently process this protein. Using this system, Miyajima et al. (1985) were able to obtain the secretion of functionally active interleukin 2. Epitopes in proteins of several viruses have been mapped by a similar technique (Madaule et al., 1991 ; Benichou et al., 1992; Noraz et al., 1993; Mink et al., 1994) . It has been demonstrated for hepatitis C virus that peptides averaging 100 amino acids in length are fully glycosylated and immunogenic only under non-denaturing conditions. This suggests that, for this virus at least, these peptides were able to mimic conformational epitopes (Mink et al., 1994) . Fragments of about 250 nucleotides of the rabies G gene were inserted into a shuttle yeast expression vector and colonies that were immunoreactive with a polyclonal serum were isolated and analysed. We have found that only WB ÷ MAbs were able to bind to peptides and we have mapped the regions of the protein which were recognized by this category of MAbs.
Methods
Cells' and viruses. The bacterial strain DH5~ (BRL) was used for transformations. Saccharomyces cerevisiae VP 209-7b (MA Tc~ leu2 ura3 cycl-1) was obtained from J. Verdi~re (CGM, CNRS, Gif-sur-Yvette, France). Yeast cells carrying plasmids were grown in synthetic medium (SD) containing 0.67 % yeast nitrogen base without amino acids, 2 % glucose and 0.5 % Casamino acids (Difco). Agarose (1.5 %) was used instead of agar for subsequent immunological screening. The rabies virus CVS strain and its antigenic mutants were grown on BSR, a clone of BHK-21 cells, in Glasgow MEM supplemented with 2 % newborn calf serum. As previously described (Self et al., 1985) the antigenic mutants were selected from 10 different CVS clones. Hybridomas were grown in Dulbecco's modified Eagle's medium supplemented with 15 % foal serum, 2mM-L-glutamine, 10 m~-sodium pyruvate and HAT (0.1 mM-hypoxanthine, 0.5 ~tM-aminopterin and 16 laM-thymidine). MAbs were isolated and characterized as previously described (Benmansour et al., 1991) .
Hybridomas secreting anti-rabies virus antibodies were initially characterized by ELISA against the whole virus and then in immunoblot analysis after SDS PAGE (under reducing conditions) and electrotransferred onto nitrocellulose sheets. The MAbs that were able to bind viral proteins after transfer were classified as Western blotpositive (WB+). Anti-G protein antibodies gave a characteristic membrane fluorescence on live CVS-infected cells by using FITCconjugated anti-mouse imnmnoglobulin (Silenius) as secondary antibody. Neutralizing MAbs were identified in a plaque assay neutralization test against the CVS strain and their assignment to the antigenic sites was determined according to which antigenic mutants they were unable to neutralize (Benmansour et al., 1991) .
Plasmid. The expression shuttle vector pSE-x was a gift of P. Madaule and has already been described (Madaule et al., 1991) . This plasmid contains the ORI region and the ampicillin resistance gene for growth in bacteria, the 2g yeast replication origins and the ura3 gene for growth in yeast. It also has the promoter and the leader sequence of the e¢ mating-type factor, followed by a unique HindIII restriction site and three stop codons in the three reading frames.
Yeast random expression library of rabies glycoprotein peptides. Bluescript plasmids containing the whole G gene were partially digested with 1 ng of DNAseI for 10 min in Mn ++ buffer. Fragments averaging 250 nucleotides in length were recovered and inserted at the HindIII restriction site of the pSE-x plasmid. The uniform representation of random fragments in the library was verified as follows: six pools of 60 colonies were assayed for PCR amplification between an oligonucleotide binding in the leader sequence of the ~ mating type and nine oligonucleotides well spaced along the G gene.
Yeast was transformed by a lithium acetate method derived from Ito et al. (1983) with 5 gg of bacterial library plasmid. Transformed yeast was plated on selective medium and replica plated three days later on nitrocellulose filters (Schleicher and Schuell). These filters, colonies up, were laid on a plate of selective medium and further incubated for two days. The yeast colonies were washed out and the print on the filter was tested for secretion of immunoreactive peptide: filters were first blocked with 5 % non-fat milk in PBS, then incubated overnight with 1/3000 dilution of a polyclonal anti-rabies virus antiserum made as mouse ascitic fluid, followed by incubation with alkaline phosphataseconjugated anti-mouse immunoglobulin (Silenius). Alkaline phosphatase activity was revealed with 12 mu-fast blue B B salt (Sigma) and 1.8 mu-fl-naphthyl phosphate. Yeast colonies secreting a peptide were detected and recovered from the master plate. For further characterization with MAbs, peroxidase-conjugated anti-mouse immunoglobulin (Sigma) followed by the chemiluminescent substrate ECL (Amersham) was preferred for its greater sensitivity.
Two pSE-x plasmids containing the nucleotide sequences encoding amino acids 2-220 and 304412, which contains the immunodominant sites II and III respectively, were also constructed.
Nucleotide sequence analysis
(i) G gene fragment inserted in pSE-x plasmid. Plasmid DNA was extracted from yeast spheroplasts prepared by digestion of their walls with 200 units of lyticase (Sigma) in 0' 1 M-citrate sodium buffer (pH 7), containing 1 M-sorbitol, 14 mM-2-mercaptoethanol, 50 mM-EDTA at 37 °C for 90 min. Spheroplasts were lysed in 0.1 M-Tris-HCI buffer (pH 9"7) containing 0.5 % SDS and 50 mM-EDTA for 30 min at 70 °C. Genomic DNA and proteins were precipitated with potassium acetate and plasmid DNA was recovered by ethanol precipitation. This DNA was used to transform bacteria. Some colonies were amplified and their plasmids were sequenced. The dideoxynucleotide chain termination method was used (Sanger et al., 1977) with the T7 sequencing kit of Pharmacia and [35S]dATP (NEN). The oligonucleotide 5' TGCCAG-CATTGCTGCT 3', binding in the leader sequence of the MA T7 gene, was used to prime the reaction.
(ii) M A R mutants. Viral RNA was extracted from 10ml of supernatant fluid from virus-infected cells and treated with proteinase K as already described (Seif et al., 1985) . Synthesis of cDNA was conducted as described by Benmansour et al. (1991) using a messengersense primer ending at the first ATG of the G gene. A PCR amplification was conducted on a Hybaid thermocycler for 30 cycles, with the same messenger-sense primer and a genomic-sense primer located near the transmembrane region. The PCR product was purified on a 0.8 % agarose gel, the band of the expected size was excised and electroeluted in a Spectra/Por 2 dialysis membrane, for 45 min at 100V. Sequencing was performed directly on the heat-denatured double-stranded DNA product, with the T7 sequencing kit (Pharmacia) according to the manufacturer's instruction, using the already described primers (Benmansour et aL, 1992) . (ii) On native virions. As already described (Flamand et al., 1993) , 5 ~tg of purified virus was incubated with serial dilutions of antibodies for 1 h at room temperature. After removing an aliquot for titration, the remainder was loaded onto 25% glycerol TNE buffer (10mM-Tri~HC1 pit 7-5, 50 mM-NaCI, 1 mM-EDTA) and centrifuged for 1 h at 35000 r.p.m, in a SW41 Beckman Rotor. The pellet was dissolved in Laemmli buffer and analysed by SDS-PAGE. Proteins were stained with Coomassie brilliant blue and the amount of immunoglobulin bound on the wild-type and the mutant was compared.
Binding capability of MAbs on M A R mutants
(iii) On denatured proteins after SDS PAGE and electrotransfer (WB) . About 1 gg of virus (wild-type or MAR mutants) was subjected to SDS-PAGE under reducing conditions. Proteins were electrotransferred onto nitrocellulose membranes. After blocking with 5 % non-fat milk, the membranes were incubated in a mixture of the WB ÷ MAb to be analysed and the anti-nucleocapsid 5D53 MAb as an internal marker. Binding was revealed with peroxidase-conjugated anti-mouse immunoglobulin followed by ECL detection.
Results

Identification of immunoreactive peptides
From 1650 yeast colonies, 19 secreted a peptide which was recognized by polyclonal sera from rabies virus- . Nitrocellulose filters were treated with a mouse anti-rabies virus polyclonal serum, followed by incubation with peroxidase-conjugated anti-mouse immunoglobulin and ECL detection. Column 1, control colony transformed by a plasmid without insert; column 2, colony synthesizing peptide 405-495; column 3, colony transformed by a plasmid containing the construction encoding amino acids 2-220; columns 4 and 5, two clones synthesizing peptide 30~412; column 6, colony synthesizing peptide 267 367.
immunized animals. The nucleotide sequences of the G gene fragments inserted in the plasmid of these immunoreactive yeast colonies were determined by sequencing. The 19 peptides overlapped and covered most of the protein except for the first 54 and the last 10 amino acids. The region between amino acids 200 and 300 was overrepresented ( Fig. 1) although it was shown by PCR analysis that all regions of the G gene were nearly equally represented in the bacterial library (data not shown). Peptides covering region 405-495 of the rabies virus G protein gave a weak signal with the polyclonal antiserum, which was enhanced when the cells were lysed in situ (Fig. 2) . Since it contained the transmembrane region, it was probably not efficiently secreted. For this reason it was not included in further studies. Peptides 202-272 and 207-295 were found twice, suggesting that the overall diversity of the library was limited and that any further screening would probably lead to the reisolation of the same peptides. 
Immunoreactivity of peptides toward a panel of MAbs
Sixteen representative MAbs recognizing immunodominant sites II and III were analysed. These two categories contain 97% of the neutralizing MAbs (Benmansour et al., 1991) . Likewise only three representatives of minor site a or six non-neutralizing WB-MAbs were used while all WB + MAbs (12) were analysed. None of the WB-MAbs was able to bind a peptide (Table 1) , although some of them were able to bind the protein after denaturation under non-reducing conditions (Benmansour et al., 1991) . Among the 12 WB + MAbs, seven were able to bind peptides (Table 1) . One of these (6A1) bound two peptides which shared amino acids 397-433, suggesting that the epitope recognized by this antibody was situated within this region of the G protein.
The other six MAbs all bound peptide 207~95 (Table 1) and therefore their respective epitopes should be localized within this sequence. Since each MAb reacted with several overlapping peptides, it was possible to determine the common sequence which should contain the epitope recognized by the MAb. A few peptides containing this sequence were not recognized by the MAb, probably because they adopted an incorrect configuration, masking the epitope or decreasing its affinity for the MAb. The epitopes recognized by the MAbs should thus be located respectively between amino acids 223~60 for 8C3, 223 272 for 8B1, 255-270 for 17D2 and 9D3, 255-276 for 1D1 and 267-276 for 5D66. Antibodies against this region were found in all anti-rabies virus sera available in our laboratory: one from a rabbit, four from hyperimmunized BALB/c mice, and three from vaccinated Swiss mice. These animals were immunized with CVS, SAD B ..... SAG2, or the street E6 rabies virus strain described by Benmansour et al. (1992) . Yeast transformed with the constructed plasmid encoding amino acids 304-412, i.e. which included site III and minor site a, gave a weak signal with a polyclonal serum which was greatly enhanced after lysis of the cells, indicating that the peptide was synthesized but poorly secreted (Fig. 2) . None of site III-or minor site a-specific MAbs was able to react with this peptide. The constructed plasmid encoding amino acids 2-220, i.e. including site II, failed to react with the polyclonal antiserum even when the yeast cells were lysed (Fig. 2) .
Isolation and sequence analysis of MAR mutants
Since three of the WB + MAbs had neutralizing activity, it was possible to compare epitope mapping by the peptide approach with MAR mutation localization. MAR mutants resistant to neutralization by 1D1 or 8C3 (two of the three WB + neutralizing MAbs) were isolated from 10 clonal populations of CVS in order to obtain independent mutants. Five mutants (X 1 to X5) resistant to neutralization by 1D1 were selected, subjected to RT-PCR amplification and their mutations located after sequencing. Three mutants had an amino acid substitution at position 264, where an arginine was replaced by a histidine (Table 2) . Although only a small portion of the G gene was sequenced (Table 2) , the fact that the same mutation was found in three independent mutants supports the hypothesis that the substitution of arginine-264 is indeed responsible for the MAR phenotype. This mutation is situated within the short amino acid sequence (255-276) which was predicted to contain the epitope recognized by IDI (see above). However, the other two mutants (X1 and X2) had a substitution outside this region, at position 392 where a valine was replaced by an alanine or a glycine. Two mutants, AH4 and AH8, were selected for their resistance to 8C3. Both had acquired an arginine in position 251 instead of tryptophan, but the new codons were different, confirming that the mutations were indeed independent (Table 2) . Again, this substitution was within the predicted interval (223 260). replacement by an alanine (Fig. 3 and Table 3 ). The binding capacities of the WB + MAbs on cells infected with the MAR mutants are summarized in Table 3 : the non-neutralizing MAb 9C3 bound very poorly on native wild-type G protein and was not assayed on the mutants. The mutation at amino acid 264 prevented the binding of 17D2 as well as that of 1D1 but did not modify that of 8C3, 8Bl and 5D66. The mutation at amino acid 251 prevented the binding of its selective MAb 8C3 as well as that of 8B1 and did not impair that of the other WB ÷ MAbs. It is therefore likely that epitopes recognized by 1D1 and 17D2 on one hand, and by 8C3 and 8B1 on the other, overlap. Since MAb 5D66 bound all MAR mutants, its epitope cannot be delineated more precisely by this approach. However, as it bound a peptide starting at position 267, its epitope should be located after this position. Because 1D1 was able to bind to cells infected with two of its MAR mutants, binding to purified MAR mutants and residual neutralization were compared. MAb 1D1 was able to neutralize X1 at concentrations 30-to 50-fold higher than for the wild-type and its reduced binding to purified virus correlated well with its reduced neutralization activity. On the other hand, X3 was completely resistant to neutralization and the MAb was unable to bind at any concentration (Table 4) .
Binding of MAbs on the mutant G proteins
(ii) On the denatured form of the protein
The binding of the MAbs on the denatured G protein of CVS and MAR mutants AH8, X1 and X3 are shown in Fig. 4 . The anti-nucleoprotein MAb indicated the amount of virus in each well. As expected all anti-G protein MAbs reacted with the CVS glycoprotein. MAR mutant AH8 (mutated at position 251) did not allow the binding of MAbs 8C3 and 8B1 but that of the three other MAbs was normal. Mutant X3 (modified at position 264) was bound neither by MAb 1D1, used for its selection, nor by 17D2 and 9D3, which are respectively poorly and non-neutralizing MAbs. The final mutant, X1, selected with 1D1 and modified at position 392 was recognized by 1D1 and by all the other MAbs.
Discussion
In order to see whether major antigenic sites of rabies virus G protein could be mimicked by peptides, we have generated peptides from a randomly digested G gene inserted in a yeast expression vector. Fragments averaging 80 amino acids in length were chosen because, in the case of hepatitis C virus, it has been shown that peptides of that size were able to mimic conformational epitopes (Mink et al., 1994) . Alternatively, shorter peptides could partially mimic the conformation of an epitope (Tormo et al., 1994) , but in the case of rabies virus G protein, synthetic peptides of 10 to 15 amino acids covering antigenic site III and minor antigenic site a were not recognized either by site III-or by minor site a-specific MAbs (P. Coulon, M. H. V. Van Regenmortel & F. Lafay, unpublished data) . Nineteen colonies secreting peptides immunoreactive with a polyclonal anti-CVS serum were selected from the yeast library. These peptides covered the G protein sequence from amino acid 54 to 494. The different regions of the glycoprotein were not equally represented, although a random distribution was found in the bacterial library. Not a single WB-MAb, out of the 28 tested, was able to recognize a peptide, even when it contained the relevant epitope. For instance a pool of site III-specific MAbs did not react with a single peptide of the library nor with an engineered peptide containing the putative antigenic site III region. In the latter case however, the peptide was poorly secreted, as shown by increased immunoreactivity toward a polyclonal serum after lysis of the cells. Our results thus suggested that conformational epitopes of the rabies virus G protein could not be mimicked by peptides. Seven of our 12 WB + MAbs, including the three neutralizing WB + MAbs, were able to recognize several peptides from our library, while the five others did not bind peptides. Either their epitopes were located in regions not represented in the library, or the epitopes were not accessible in the peptides. Two regions of the G protein were recognized by WB + MAbs. The first, defined by one non-neutralizing MAb (6A1), was located between amino acids 397 and 433. The second, defined by three non-neutralizing and three neutralizing MAbs, extended between amino acids 223-276. Each MAb had a unique binding pattern with overlapping peptides, allowing the delineation of its epitope within sequences ranging from 10-38 amino acids long.
The selection and sequence determination of mutants resisting neutralization by 1D 1 and 8C3, two of the WB + neutralizing MAbs, allowed the localization of the mutations responsible for the MAR phenotype. Five MAR mutants had a modified amino acid within the region revealed by the peptide approach, thus directly confirming the reliability and complementarity of the two approaches to epitope mapping. However, two mutants resisting neutralization by 1D1 had an amino acid substitution in position 392, i.e. outside the region containing the epitope. Although the whole gene had not been sequenced, this modification is very likely to be responsible for the resistant phenotype since the same amino acid was modified in different ways in two mutants. Moreover, another mutant, isolated for its resistance to acid-induced neutralization with MAb 17A4, had the same pattern of resistance toward MAbs 1D1 and 8C3 and the same nucleotide substitution as X1 (Raux et al., 1995) . No other substitution was found in nucleotides encoding amino acids 1-62 or 126-435 (H. Raux, personal communication) .
We investigated whether MAR mutants were still able to bind MAbs. The two MAR mutants modified at position 251 were unable to bind their selective MAb 8C3 or MAb 8B1 under denaturing conditions and, as expected, were resistant to neutralization by these two MAbs. These mutants behaved like wild-type virus toward the other MAbs. Therefore the epitopes of 8C3 and 8B1 should overlap. Similarly, the epitopes of 1D1, 9D3 and 17D2 MAbs must overlap since a mutation at position 264 prevents the binding of all three MAbs. According to Benmansour et al. (1991) these MAbs would define a new minor antigenic region, probably including two minor sites: b (MAbs 8C3 and 8B1) and c (1D1, 9D3 and 17D2). The epitope of the last MAb (5D66), situated between amino acids 267-276 is not affected by mutations at position 251 or 264 and probably closely follows site c, if it is not included in this site. A mutation at position 264 was also found in a MAR mutant selected with another WB ÷ MAb, 6-15C4 (Bunschoten et al., 1989; Dietzschold et al., 1990b) . This suggests that the corresponding linear epitope, which was characterized with synthetic peptides (Van der Heijden et al., 1993 ) also belongs to minor antigenic site c. Therefore the peptide strategy indicates as highly immunodominant a region of the G protein which is only recognized by half of our WB + MAbs, a category which represents only 2% of our MAbs. Should this observation be generalized, it would mean that the peptide approach, although it has been successfully used to map some neutralizing epitopes of viral antigens (Muller et al., 1982; Parry et al., 1989; Rini et al., 1993) is not suitable for the characterization of complex major antigenic sites as those of rabies virus G protein.
The neutralizing activity of the three MAbs defining site c varied from high (1D1), weak (17D2), to nil (9D3). This last MAb was also virtually unable to bind to the native form of the G protein, indicating that its epitope was only accessible on the denatured protein. In the native form of the G protein, minor site c should thus be partially buried. This could explain why synthetic peptides of this region are poorly efficient for mice vaccination (Dietzschold et al., 1990b) . In our hands the amount of peptides secreted by the yeast was low, impairing their assay as vaccines.
The mutation at position 392, which is outside the epitope of 1D 1, decreased the binding of this MAb to the native protein, explaining why mutants X1 and X2 escaped neutralization under standard conditions. This mutation did not affect the binding of the WB + MAbs, including 1D1, on denatured protein, suggesting that position 392 probably modified at a distance the accessibility of minor site c on the native protein. Such a mechanism, involving remote mutations in the modification of an antigenic site, has previously been described for foot-and-mouth disease virus (Parry et al., 1990) .
It would be interesting to define more precisely the epitopes recognized by the MAbs, as has been done for 6-15C4 (van der Heijden et al., 1993) and to determine the smallest synthetic peptides that can be efficiently recognized. If some of our WB + MAbs have a good affinity for a short oligopeptide, this amino acid sequence could be used as a reporter target for immunodetection of chimeric constructions.
